Y-Intercept (HK)’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.9M Sell
48,491
-17,724
-27% -$1.84M 0.1% 281
2026
Q1
$6.4M Sell
66,215
-28,247
-30% -$2.9M 0.12% 238
2025
Q4
$10M Buy
94,462
+87,460
+1,249% +$10.1M 0.22% 69
2025
Q3
$889K Sell
7,002
-14,889
-68% -$1.77M 0.02% 1030
2025
Q2
$2.68M Buy
21,891
+16,908
+339% +$1.93M 0.07% 470
2025
Q1
$505K Buy
+4,983
New +$487K 0.03% 695
2024
Q4
Sell
-9,720
Closed -$939K 1298
2024
Q3
$939K Buy
+9,720
New +$873K 0.06% 472
2024
Q1
Sell
-7,308
Closed -$488K 1465
2023
Q4
$488K Buy
+7,308
New +$473K 0.05% 611
2022
Q3
Sell
-9,664
Closed -$431K 1052
2022
Q2
$431K Buy
9,664
+5,507
+132% +$283K 0.06% 472
2022
Q1
$235K Buy
+4,157
New +$217K 0.05% 554
2021
Q1
Sell
-3,591
Closed -$235K 663
2020
Q4
$235K Buy
+3,591
New +$211K 0.1% 402

Other funds holding EHC

Y-Intercept (HK)'s EHC Position: Q2 2026 in Review

Y-Intercept (HK) reduced its Encompass Health (EHC) stake by 27% in Q2 2026, selling an estimated $1.84M and leaving 48,491 shares worth $4.9M. The position accounts for 0.1% of the portfolio, ranked #281.

Y-Intercept (HK) first reported a position in EHC in Q4 2020 and has held it in 11 quarters since. The position peaked at $10M in Q4 2025. 113 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Y-Intercept (HK) held 48,491 shares of Encompass Health worth $4.9M as of Q2 2026.
  • Y-Intercept (HK) sold 17,724 Encompass Health shares in Q2 2026, an estimated $1.84M.
  • Encompass Health made up 0.1% of Y-Intercept (HK)'s portfolio in Q2 2026, its #281 holding.
  • Y-Intercept (HK) first reported a position in Encompass Health in Q4 2020 and has held it in 11 quarters since.
  • Y-Intercept (HK)'s Encompass Health position peaked at $10M in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.